Miller Howard Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,757
Closed -$559K 184
2024
Q3
$559K Sell
7,757
-5
-0.1% -$354 0.02% 153
2024
Q2
$534K Buy
7,762
+165
+2% +$11.2K 0.02% 150
2024
Q1
$551K Buy
7,597
+47
+0.6% +$3.14K 0.02% 151
2023
Q4
$462K Buy
7,550
+92
+1% +$5.46K 0.02% 158
2023
Q3
$427K Sell
7,458
-14
-0.2% -$846 0.02% 151
2023
Q2
$444K Buy
7,472
+47
+0.6% +$2.81K 0.02% 156
2023
Q1
$465K Buy
7,425
+81
+1% +$5.06K 0.02% 153
2022
Q4
$460K Buy
7,344
+1
+0% +$57 0.02% 153
2022
Q3
$366K Buy
7,343
+17
+0.2% +$941 0.02% 161
2022
Q2
$431K Buy
+7,326
New +$404K 0.02% 155

Other funds holding PBH

Miller Howard Investments's PBH Position: Q4 2024 in Review

Miller Howard Investments sold out of Prestige Consumer Healthcare (PBH) in Q4 2024, closing a stake of 7,757 shares — an estimated $559K sold.

Miller Howard Investments first reported a position in PBH in Q2 2022 and held it in 10 quarters. The position peaked at $559K in Q3 2024. 336 funds tracked by Wall St. Rank hold PBH as of Q4 2024.

  • Miller Howard Investments reported no remaining Prestige Consumer Healthcare position as of Q4 2024 after selling out during the quarter.
  • Miller Howard Investments sold 7,757 Prestige Consumer Healthcare shares in Q4 2024, an estimated $559K.
  • Miller Howard Investments first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 10 quarters.
  • Miller Howard Investments's Prestige Consumer Healthcare position peaked at $559K in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2024.

Based on Miller Howard Investments's 13F filing for Q4 2024, filed 28 Jan 2025.